U.S. flag

An official website of the United States government

NM_000465.4(BARD1):c.17A>T (p.Gln6Leu) AND Familial cancer of breast

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Mar 9, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001301889.8

Allele description [Variation Report for NM_000465.4(BARD1):c.17A>T (p.Gln6Leu)]

NM_000465.4(BARD1):c.17A>T (p.Gln6Leu)

Gene:
BARD1:BRCA1 associated RING domain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q35
Genomic location:
Preferred name:
NM_000465.4(BARD1):c.17A>T (p.Gln6Leu)
HGVS:
  • NC_000002.12:g.214809553T>A
  • NG_012047.3:g.5159A>T
  • NM_000465.4:c.17A>TMANE SELECT
  • NM_001282543.2:c.17A>T
  • NM_001282545.2:c.17A>T
  • NM_001282548.2:c.17A>T
  • NM_001282549.2:c.17A>T
  • NP_000456.2:p.Gln6Leu
  • NP_001269472.1:p.Gln6Leu
  • NP_001269474.1:p.Gln6Leu
  • NP_001269477.1:p.Gln6Leu
  • NP_001269478.1:p.Gln6Leu
  • LRG_297t1:c.17A>T
  • LRG_297:g.5159A>T
  • LRG_297p1:p.Gln6Leu
  • NC_000002.11:g.215674277T>A
  • NG_012047.2:g.5152A>T
  • NR_104212.2:n.131A>T
  • NR_104215.2:n.131A>T
  • NR_104216.2:n.131A>T
Protein change:
Q6L
Links:
dbSNP: rs864622229
NCBI 1000 Genomes Browser:
rs864622229
Molecular consequence:
  • NM_000465.4:c.17A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282543.2:c.17A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282545.2:c.17A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282548.2:c.17A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282549.2:c.17A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_104212.2:n.131A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104215.2:n.131A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_104216.2:n.131A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001491074Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Mar 9, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001491074.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with BARD1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change replaces glutamine with leucine at codon 6 of the BARD1 protein (p.Gln6Leu). The glutamine residue is weakly conserved and there is a moderate physicochemical difference between glutamine and leucine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024